Advances and surgical considerations in the treatment of moyamoya disease

Neurosurgery

Volumn 74, Issue 2 SUPPL., 2014, Pages

  Arias, Eric J ^a   Derdeyn, Colin P ^a   Dacey, Ralph G ^a   Zipfel, Gregory J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cerebral revascularization; Hemorrhagic stroke; Ischemic stroke; Moyamoya; Natural history; STAMCA bypass

Indexed keywords

INDOCYANINE GREEN;

ANTERIOR CEREBRAL ARTERY; ARTICLE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CEREBRAL REVASCULARIZATION; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONVENTIONAL ANGIOGRAPHY; DIGITAL SUBTRACTION ANGIOGRAPHY; DISEASE COURSE; EXTERNAL CAROTID ARTERY; FAMILIAL DISEASE; GOLD STANDARD; HEMODYNAMICS; HUMAN; INTELLECTUAL IMPAIRMENT; INTERNAL CAROTID ARTERY; MEDICAL HISTORY; MIDDLE CEREBRAL ARTERY; MOTOR DYSFUNCTION; MOYAMOYA DISEASE; NEUROIMAGING; NEUROSURGERY; OUTCOME ASSESSMENT; OXYGEN EXTRACTION FRACTION; PATHOPHYSIOLOGY; PATIENT MONITORING; PEROPERATIVE COMPLICATION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SUPERFICIAL TEMPORAL ARTERY; SURGICAL TECHNIQUE;

CEREBRAL REVASCULARIZATION; HUMANS; MOYAMOYA DISEASE; RISK; STROKE; TREATMENT OUTCOME;

EID: 84892927664     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/NEU.0000000000000229     Document Type: Article

References (73)

1. Suzuki J, Takaku A. Cerebrovascular "moyamoya" disease: Disease showing abnormal net-like vessels in base of brain. Arch Neurol. 1969;20(3):288-299
2. Suzuki J, Kodama N. Moyamoya disease: A review. Stroke. 1983;14(1):104-109
3. Park EK, Lee YH, Shim KW, et al. Natural history and progression factors of unilateral moyamoya disease in pediatric patients. Childs Nerv Syst. 2011;27(8): 1281-1287
4. Kim SK, Seol HJ, Cho BK, et al. Moyamoya disease among young patients: Its aggressive clinical course and the role of active surgical treatment. Neurosurgery. 2004;54(4):840-844; discussion 844-846
5. Han DH, Nam DH, Oh CW. Moyamoya disease in adults: Characteristics of clinical presentation and outcome after encephalo-duro-arterio-synangiosis. Clin Neurol Neurosurg. 1997;99(suppl 2):S151-S155
6. Ikezaki K, Inamura T, Kawano T, et al. Clinical features of probable moyamoya disease in Japan. Clin Neurol Neurosurg. 1997;99(suppl 2):S173-S177
7. Yim SH, Cho CB, Joo WI, et al. Prevalence and epidemiological features of moyamoya disease in Korea. J Cerebrovasc Endovasc Neurosurg. 2012;14(2):75-78
8. Wakai K, Tamakoshi A, Ikezaki K, et al. Epidemiological features of moyamoya disease in Japan: Findings from a nationwide survey. Clin Neurol Neurosurg. 1997; 99(suppl 2):S1-S5
9. Kuriyama S, Kusaka Y, Fujimura M, et al. Prevalence and clinicoepidemiological features of moyamoya disease in Japan: Findings from a nationwide epidemiological survey. Stroke. 2008;39(1):42-47
10. Baba T, Houkin K, Kuroda S. Novel epidemiological features of moyamoya disease. J Neurol Neurosurg Psychiatry. 2008;79(8):900-904
11. Bruno A, Adams HP Jr, Biller J, Rezai K, Cornell S, Aschenbrener CA. Cerebral infarction due to moyamoya disease in young adults. Stroke. 1988;19(7):826-833
12. Chiu D, Shedden P, Bratina P, et al. Clinical features of moyamoya disease in the United States. Stroke. 1998;29(7):1347-1351
13. Hallemeier CL, Rich KM, Grubb RL Jr, et al. Clinical features and outcome in North American adults with moyamoya phenomenon. Stroke. 2006;37(6): 1490-1496
14. Starke RM, Crowley RW, Maltenfort M, et al. Moyamoya disorder in the United States. Neurosurgery. 2012;71(1):93-99
15. Kraemer M, Heienbrok W, Berlit P. Moyamoya disease in Europeans. Stroke. 2008;39(12):3193-3200
16. Scott RM, Smith ER. Moyamoya disease and moyamoya syndrome. N Engl JMed. 2009;360(12):1226-1237
17. Gross BA, Du R. The natural history of moyamoya in a North American adult cohort. J Clin Neurosci. 2013;20(1):44-48
18. Jiang T, Perry A, Dacey RG Jr, et al. Intracranial atherosclerotic disease associated with moyamoya collateral formation: Histopathological findings. J Neurosurg. 2013;118(5):1030-1034
19. Bitzer M, Topka H. Progressive cerebral occlusive disease after radiation therapy. Stroke. 1995;26(1):131-136
20. Merkel KH, Ginsberg PL, Parker JC Jr, et al. Cerebrovascular disease in sickle cell anemia: A clinical, pathological and radiological correlation. Stroke. 1978;9(1): 45-52
21. Pearson E, Lenn NJ, Cail WS. Moyamoya and other causes of stroke in patients with Down syndrome. Pediatr Neurol. 1985;1(3):174-179
22. Erickson RP, Woolliscroft J, Allen RJ. Familial occurrence of intracranial arterial occlusive disease (Moyamoya) in neurofibromatosis. Clin Genet. 1980; 18(3):191-196
23. Uchino K, Johnston SC, Becker KJ, et al. Moyamoya disease in Washington state and California. Neurology. 2005;65(6):956-958
24. Kurokawa T, Tomita S, Ueda K, et al. Prognosis of occlusive disease of the circle of Willis (moyamoya disease) in children. Pediatr Neurol. 1985;1(5):274-277
25. Choi JU, Kim DS, Kim EY, et al. Natural history of moyamoya disease: Comparison of activity of daily living in surgery and non surgery groups. Clin Neurol Neurosurg. 1997;99(suppl 2):S11-S18
26. Imaizumi T, Hayashi K, Saito K, et al. Long-term outcomes of pediatric moyamoya disease monitored to adulthood. Pediatr Neurol. 1998;18(4):321-325
27. Fukuyama Y, Umezu R. Clinical and cerebral angiographic evolutions of idiopathic progressive occlusive disease of the circle of Willis ("moyamoya" disease) in children. Brain Dev. 1985;7(1):21-37
28. Fujii K, Ikezaki K, Irikura K, et al. The efficacy of bypass surgery for the patients with hemorrhagic moyamoya disease. Clin Neurol Neurosurg. 1997;99(suppl 2): S194-S195
29. Kobayashi E, Saeki N, Oishi H, et al. Long-term natural history of hemorrhagic moyamoya disease in 42 patients. J Neurosurg. 2000;93(6):976-980
30. Zipfel GJ, Sagar J, Miller JP, et al. Cerebral hemodynamics as a predictor of stroke in adult patients with moyamoya disease: A prospective observational study. Neurosurg Focus. 2009;26(4):E6
31. Peerless SJ. Risk factors of moyamoya disease in Canada and the USA. Clin Neurol Neurosurg. 1997;99(suppl 2):S45-S48
32. Goyal MS, Hallemeier CL, Zipfel GJ, et al. Clinical features and outcome in North American adults with idiopathic basal arterial occlusive disease without moyamoya collaterals. Neurosurgery. 2010;67(2):278-285
33. Ikeda H, Sasaki T, Yoshimoto T, et al. Mapping of a familial moyamoya disease gene to chromosome 3p24.2-p26. Am J Hum Genet. 1999;64(2):533-537
34. Nanba R, Tada M, Kuroda S, et al. Sequence analysis and bioinformatics analysis of chromosome 17q25 in familial moyamoya disease. Childs Nerv Syst. 2005;21(1): 62-68
35. Han H, Pyo CW, Yoo DS, et al. Associations of Moyamoya patients with HLA class I and class II alleles in the Korean population. J Korean Med Sci. 2003;18(6): 876-880
36. Sakurai K, Horiuchi Y, Ikeda H, et al. A novel susceptibility locus for moyamoya disease on chromosome 8q23. J Hum Genet. 2004;49(5):278-281
37. Kamada F, Aoki Y, Narisawa A, et al. A genome-wide association study identifies RNF213 as the first moyamoya disease gene. J Hum Genet. 2011;56(1):34-40
38. Miskinyte S, Butler MG, Hervé D, et al. Loss of BRCC3 deubiquitinating enzyme leads to abnormal angiogenesis and is associated with syndromic moyamoya. Am J Hum Genet. 2011;88(6):718-728
39. Bower RS, Mallory GW, Nwojo M, Kudva YC, Flemming KD, Meyer FB. Moyamoya disease in a primarily white, Midwestern US population: Increased prevalence of autoimmune disease. Stroke. 2013;44(7):1997-1999
40. Kim SJ, Heo KG, Shin HY, et al. Association of thyroid autoantibodies with moyamoya-type cerebrovascular disease: A prospective study. Stroke. 2010;41(1): 173-176
41. Jeong HC, Kim YJ, Yoon W, et al. Moyamoya syndrome associated with systemic lupus erythematosus. Lupus. 2008;17(7):679-682
42. Yoshimoto T, Houkin K, Takahashi A, et al. Angiogenic factors in moyamoya disease. Stroke. 1996;27(12):2160-2165
43. Aoyagi M, Fukai N, Yamamoto M, et al. Early development of intimal thickening in superficial temporal arteries in patients with moyamoya disease. Stroke. 1996;27 (10):1750-1754
44. Nanba R, Kuroda S, Ishikawa T, et al. Increased expression of hepatocyte growth factor in cerebrospinal fluid and intracranial artery in moyamoya disease. Stroke. 2004;35(12):2837-2842
45. Pandey P, Steinberg GK. Neurosurgical advances in the treatment of moyamoya disease. Stroke. 2011;42(11):3304-3310
46. Fujimura M, Watanabe M, Narisawa A, et al. Increased expression of serum matrix metalloproteinase-9 in patients with moyamoya disease. Surg Neurol. 2009;72(5): 476-480; discussion 480
47. Hoshi H, Ohnishi T, Jinnouchi S, et al. Cerebral blood flow study in patients with moyamoya disease evaluated by IMP SPECT. J Nucl Med. 1994;35(1):44-50
48. Garrett MC, Komotar RJ, Starke RM, et al. Radiographic and clinical predictors of hemodynamic insufficiency in patients with athero-occlusive disease. J Stroke Cerebrovasc Dis. 2008;17(6):340-343
49. Noguchi T, Kawashima M, Irie H, et al. Arterial spin-labeling MR imaging in moyamoya disease compared with SPECT imaging. Eur J Radiol. 2011;80(3): E557-e62
50. Zhang J, Jianhong W, Daoying G, et al. Whole-brain CT perfusion and CT angiography assessment of moyamoya disease before and after surgical revascularization: Preliminary study with 256-slice CT. PLoS One. 2013;8(2):e57595
51. Takase K, Kashihara M, Hashimoto T. Transcranial Doppler ultrasonography in patients with moyamoya disease. Clin Neurol Neurosurg. 1997;99(suppl 2): S101-S105
52. Ashley WWJr, Zipfel GJ, Moran CJ, et al. Moyamoya phenomenon secondary to intracranial atherosclerotic disease: Diagnosis by 3T magnetic resonance imaging. J Neuroimaging. 2009;19(4):381-384
53. Nakagawa I, Kurokawa S, Tanisaka M, et al. Virtual surgical planning for superficial temporal artery to middle cerebral artery bypass using three-dimensional digital subtraction angiography. Acta Neurochir (Wien). 2010;152(9):1535-1540; discussion 1541
54. Kikuta K, Takagi Y, Fushimi Y, et al. "Target bypass": A method for preoperative targeting of a recipient artery in superficial temporal artery-to-middle cerebral artery anastomoses. Neurosurgery. 2008;62(6 suppl 3):1434-1441
55. Donaghy RM, Yaşargil G. Microangeional surgery and its techniques. Prog Brain Res. 1968;30:263-267
56. Zipfel GJ, Fox DJ Jr, Rivet DJ. Moyamoya disease in adults: The role of cerebral revascularization. Skull Base. 2005;15(1):27-41
57. Oliveira RS, Amato MC, Simão GN, et al. Effect of multiple cranial burr hole surgery on prevention of recurrent ischemic attacks in children with moyamoya disease. Neuropediatrics. 2009;40(6):260-264
58. Calviere L, Catalaa I, Marlats F, et al. Correlation between cognitive impairment and cerebral hemodynamic disturbances on perfusion magnetic resonance imaging in European adults with moyamoya disease: Clinical article. J Neurosurg. 2010;113 (4):753-759
59. Ishikawa T, Houkin K, Kamiyama H, et al. Effects of surgical revascularization on outcome of patients with pediatric moyamoya disease. Stroke. 1997;28(6): 1170-1173
60. Scott RM, Smith JL, Robertson RL, et al. Long-term outcome in children with moyamoya syndrome after cranial revascularization by pial synangiosis. J Neurosurg. 2004;100(2 suppl Pediatrics):142-149
61. Liu X, Zhang D, Shuo W, et al. Long term outcome after conservative and surgical treatment of haemorrhagic moyamoya disease. J Neurol Neurosurg Psychiatry. 2013; 84(3):258-265
62. Kawaguchi S, Okuno S, Sakaki T. Effect of direct arterial bypass on the prevention of future stroke in patients with the hemorrhagic variety of moyamoya disease. J Neurosurg. 2000;93(3):397-401
63. Yoshida Y, Yoshimoto T, Shirane R, et al. Clinical course, surgical management, and long-term outcome of moyamoya patients with rebleeding after an episode of intracerebral hemorrhage: An extensive follow-Up study. Stroke. 1999;30(11): 2272-2276
64. Miyamoto S. Study design for a prospective randomized trial of extracranialintracranial bypass surgery for adults with moyamoya disease and hemorrhagic onset: The Japan Adult Moyamoya Trial Group. NeurolMed Chir (Tokyo). 2004;44 (4):218-219
65. Guzman R, Lee M, Achrol A, et al. Clinical outcome after 450 revascularization procedures for moyamoya disease: Clinical article. J Neurosurg. 2009;111(5):927-935
66. Starke RM, Komotar RJ, Hickman ZL, et al. Clinical features, surgical treatment, and long-term outcome in adult patients with moyamoya disease: Clinical article. J Neurosurg. 2009;111(5):936-942
67. Sato K, Shirane R, Kato M, et al. Effect of inhalational anesthesia on cerebral circulation in moyamoya disease. J Neurosurg Anesthesiol. 1999;11(1):25-30
68. Woitzik J, Horn P, Vajkoczy P, et al. Intraoperative control of extracranialintracranial bypass patency by near-infrared indocyanine green videoangiography. J Neurosurg. 2005;102(4):692-698
69. Amin-Hanjani S, Du X, Mlinarevich N, et al. The cut flow index: An intraoperative predictor of the success of extracranial-intracranial bypass for occlusive cerebrovascular disease. Neurosurgery. 2005;56(suppl 1):75-85; discussion 75-85
70. Lee M, Guzman R, Bell-Stephens T, et al. Intraoperative blood flow analysis of direct revascularization procedures in patients with moyamoya disease. J Cereb Blood Flow Metab. 2011;31(1):262-274
71. Langer DJ, Van Der Zwan A, Vajkoczy P, et al. Excimer laser-assisted nonocclusive anastomosis: An emerging technology for use in the creation of intracranialintracranial and extracranial-intracranial cerebral bypass. Neurosurg Focus. 2008;24 (2):E6
72. Dacey RG, Zipfel GJ, Ashley WW, et al. Automated, compliant, high-flow common carotid to middle cerebral artery bypass. J Neurosurg. 2008;109(3): 559-564
73. Hanggi D, Reinert M, Steiger HJ. C-Port Flex-A-assisted automated anastomosis for high-flow extracranial-intracranial bypass surgery in patients with symptomatic carotid artery occlusion: A feasibility study: Clinical article. J Neurosurg. 2009;111 (1):181-187